|
Jan 2
|
7 Magnificent Stocks That Can Double Your Money in 2024
|
|
Dec 19
|
Owning 48% shares,institutional owners seem interested in Novavax, Inc. (NASDAQ:NVAX),
|
|
Dec 18
|
Novavax's Updated COVID-19 Vaccine Receives Emergency Use Authorization in Taiwan
|
|
Dec 18
|
3 Meme Stocks That Could Fade Away in 2024
|
|
Dec 14
|
UPDATE 2-US CDC says there's urgent need to increase respiratory vaccine coverage
|
|
Dec 13
|
Canadians Can Help Protect Loved Ones as We Head into the Holiday Season
|
|
Dec 5
|
UPDATE 1-Health Canada authorizes Novavax's updated COVID shot for Omicron
|
|
Dec 5
|
Novavax's Updated COVID-19 Vaccine Now Authorized in Canada
|
|
Dec 1
|
Is Novavax Stock a Buy Now?
|
|
Nov 30
|
‘Nobody wants to speak about COVID’: Less than 3% of eligible Americans got a booster shot in September — does that mean trouble for these 3 big vaccine stocks?
|
|
Nov 29
|
Novavax's (NVAX) Updated COVID Jab Gets WHO Nod for Emergency Use
|
|
Nov 28
|
UPDATE 2-WHO authorizes emergency use of Novavax's updated COVID shot
|
|
Nov 28
|
Novavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health Organization
|
|
Nov 17
|
Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities
|
|
Nov 15
|
Could a Short Squeeze Be Coming for These 3 Heavily Shorted Stocks?
|
|
Nov 2
|
Down 75% From Its High, Has Novavax Stock Become Too Cheap to Pass Up?
|
|
Nov 2
|
Novavax to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Operational Highlights on November 9, 2023
|
|
Sep 26
|
A Struggling Covid Vaccine Maker Tops List of Most-Shorted Stocks
|
|
Sep 25
|
New COVID vaccine rollout running into insurance, supply roadblocks
|
|
Sep 13
|
The Zacks Analyst Blog Highlights Pfizer, BioNTech, Moderna and Novavax
|